Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV) is one component of the two-part PVL toxin secreted by *Staphylococcus aureus*. PVL functions as a bi-component exotoxin composed of LukS-PV (S component) and LukF-PV (F component), which together form octameric β-barrel pores in the membranes of immune cells such as neutrophils and macrophages. LukS-PV binds first to specific host cell receptors, enabling LukF-PV to join, resulting in pore formation and rapid cell lysis. This mechanism is a major virulence factor in severe *S. aureus* infections, including community-acquired MRSA, skin abscesses, and necrotizing pneumonia. The gene encoding LukS-PV is located on lysogenic bacteriophages in *S. aureus*, and its presence is associated with increased bacterial virulence and poor clinical outcomes.
The LukS-PV binds first to specific receptors on the host immune cell surface, enables recruitment of the F component (LukF-PV), then together assemble into an oligomeric pore that disrupts cell membranes, causing lysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV).